Clinical Research Directory
Browse clinical research sites, groups, and studies.
WATER III: Aquablation vs. Transurethral Laser Enucleation of Large Prostates (80 - 180mL) in Benign Prostatic Hyperplasia
Sponsor: University of Bonn
Summary
Comparative analysis of efficacy and safety of Aquablation (AQUABEAM Robotic System®, PROCEPT BioRobotics, Redwood City, CA, USA) and transurethral laser enucleation as surgical therapy for benign prostatic hyperplasia with large prostates (80-180ml).
Official title: WATER III: Aquablation vs. Transurethral Laser Enucleation of Large Prostates (80-180ml) in Benign Prostatic Hyperplasia
Key Details
Gender
MALE
Age Range
45 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
202
Start Date
2020-12-16
Completion Date
2029-10
Last Updated
2025-02-06
Healthy Volunteers
No
Interventions
Aquablation therapy
Aquablation is carried out with the AQUABEAM Robotic System®, PROCEPT BioRobotics, Redwood City, CA, USA
Transurethral laser enucleation
Transurethral laser enucleation is performed according to the standard established at the respective test center. Included laser techniques: Holmium laser (HoLEP) and Thulium laser (ThuLEP).
Locations (5)
Department of Urology, University Hospital Freiburg
Freiburg im Breisgau, Baden-Wurttemberg, Germany
Department of Urology, Augusta-Kranken-Anstalt, Bochum Mitte
Bochum, North Rhine-Westphalia, Germany
Department of Urology, University Hospital Bonn
Bonn, North Rhine-Westphalia, Germany
Frimley Health NHS Foundation Trust
London, United Kingdom
Guy's and St. Thomas' Hospital
London, United Kingdom